(Q44344143)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

C V Jensen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H B W Larsson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J L Frederiksen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

102-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12617276%20AND%20SRC:MED&resulttype=core&format=json

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice .

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR

Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS880SR